Trimeris, Inc. (TRMS)
A biopharmaceutical company primarily engaged in the discovery, development and commercialization of a new class of antiviral drug treatments called fusion inhibitors.
Recs
I'm just here for the dividends
Recs
solid health care products company
Recs
THIS COMPANIES PROFITS HAVE DOUBLED
Recs
Leader in anti-viral drug treatments, and the world will continue to fund this type of research, Leader in anti-HIV drug research.
Recs
Something must give on this HIV desease.So,this Bio-tech Co. is one of the best @ $6.59 I'm looking for a run-up to $14.00 Buy November 2008.
Recs
Stellar cash flow. With financials like this the SP is sure to turnaround. Largely owned by institutions so watch for big price moves on the moving averages. On paper it looks golden, let's hope that translates into bags of money.
Recs
The company appears to be relying on collaborations with big pharma, which sends me a signal that it will stay small and only marginally profitable if at all. It expects only modest growth of its product Fuzion, despite the fact that an HIV targeted drug with new or better technology should be a big winner, suggesting that perhaps the technology is over-rated, or that its deals with Roche would not yield much revenue.
Also, most of the stock is owned by large investors and they get impatient pretty quickly and will dump when there is an upturn, leaving the rest of us hanging.
Recs
Down on CEO departure, but solid sales and earnings, good buy opportunity.
Recs
buy
Recs
Surprise growth in its HIV drug.
Recs
Buy this company before the earnings announcement. This will be their first quarter of steady positive earnings (actually their second positive quarter ever). The stock is down a lot over the past couple of years, but now the company is actually going to be profitable. The growth estimates look phenominal too. Hopefully the reason that the stock has gone downis not because people know something that isn't announced, but because they are just now making real money. Watch the earnings report closely, hopefully this company has bottomed.

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 11 of 11